LOS ANGELES, Jan. 7, 2026 /PRNewswire/ — Westcove Partners, LLC (“Westcove”), a highly specialized investment bank, announced that it acted as the exclusive financialLOS ANGELES, Jan. 7, 2026 /PRNewswire/ — Westcove Partners, LLC (“Westcove”), a highly specialized investment bank, announced that it acted as the exclusive financial

Westcove Advises Tampa Bay Medical Research in its Partnership with Alcanza Clinical Research

LOS ANGELES, Jan. 7, 2026 /PRNewswire/ — Westcove Partners, LLC (“Westcove”), a highly specialized investment bank, announced that it acted as the exclusive financial advisor to Tampa Bay Medical Research (“TBMR”) in its partnership with Alcanza Clinical Research, a portfolio company of Martis Capital (“Martis”). The terms of the transaction were not disclosed. Westcove’s deal team included Justin Hand, Managing Director; Bill Bolding, Vice President; Geno Catalano, Associate; and Andrew Hartono, Analyst.

Tampa Bay Medical Research is an independent clinical research site with dedicated facilities in Clearwater and Largo, Florida. The Company conducts Phase II–IV trials across a broad range of therapeutic areas, including MASH/MASLD, metabolic disease, endocrinology, vaccines, and others. Backed by experienced leadership, strong sponsor relationships, and a community-first approach, the Company consistently delivers reliable enrollment and high-quality trial execution.

Dr. Sureka Bollepalli, owner of TBMR, stated, “The Westcove team was always available, communicated clearly, and kept the process organized from start to finish. It was clear they had our best interests in mind, which gave us confidence throughout the transaction.”

Bill Bolding, Vice President of Westcove, commented, “Dr. Bollepalli has built a high-quality clinical research platform with a strong track record of execution. Alcanza is a natural partner for TBMR, bringing scale and infrastructure that support continued growth while preserving the strengths of the existing site. We were pleased to advise TBMR on this transaction.”

About Tampa Bay Medical Research
Tampa Bay Medical Research is an independent clinical research organization dedicated to advancing health and quality of life in its community through high-quality clinical trials. TBMR collaborates with sponsors and contract research organizations across multiple therapeutic areas, offering clinical expertise, disciplined operations, and patient-centered care to support the development of new therapies. For more information, visit www.tampabaymedicalresearch.com.

About Alcanza Clinical Research
Alcanza is an integrated network of research facilities dedicated to accelerating the development of new therapies by reducing barriers to clinical research participation. With locations across the United States, including Puerto Rico, Alcanza collaborates with medical providers and community organizations to deliver high-quality clinical research opportunities, emphasizing inclusivity and patient safety. For more information, visit www.alcanzaclinical.com.

About Martis Capital Management
Martis Capital is a healthcare-focused private equity firm that partners with founders, entrepreneurs, and management teams to build leading growth platforms in middle-market healthcare. With offices in Washington, D.C., San Francisco, and Miami, Martis Capital’s mission is to advance healthcare innovation by supporting companies that improve patient outcomes, enhance efficiency, and expand access to care. For more information, visit www.martiscapital.com.

About Westcove Partners
Westcove Partners is a premier healthcare-focused investment bank specializing in mergers and acquisitions, debt and equity financings, and other complex corporate finance transactions. The firm is dedicated to advising founder-operated businesses, tailoring its advisory services to address the unique challenges and opportunities these businesses face. For more information, visit www.westcove.com.

Contact:
Andrew Hartono, [email protected]

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/westcove-advises-tampa-bay-medical-research-in-its-partnership-with-alcanza-clinical-research-302655788.html

SOURCE Westcove Partners, LLC

Market Opportunity
Marina Protocol Logo
Marina Protocol Price(BAY)
$0.02785
$0.02785$0.02785
-4.45%
USD
Marina Protocol (BAY) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Ethereum unveils roadmap focusing on scaling, interoperability, and security at Japan Dev Conference

Ethereum unveils roadmap focusing on scaling, interoperability, and security at Japan Dev Conference

The post Ethereum unveils roadmap focusing on scaling, interoperability, and security at Japan Dev Conference appeared on BitcoinEthereumNews.com. Key Takeaways Ethereum’s new roadmap was presented by Vitalik Buterin at the Japan Dev Conference. Short-term priorities include Layer 1 scaling and raising gas limits to enhance transaction throughput. Vitalik Buterin presented Ethereum’s development roadmap at the Japan Dev Conference today, outlining the blockchain platform’s priorities across multiple timeframes. The short-term goals focus on scaling solutions and increasing Layer 1 gas limits to improve transaction capacity. Mid-term objectives target enhanced cross-Layer 2 interoperability and faster network responsiveness to create a more seamless user experience across different scaling solutions. The long-term vision emphasizes building a secure, simple, quantum-resistant, and formally verified minimalist Ethereum network. This approach aims to future-proof the platform against emerging technological threats while maintaining its core functionality. The roadmap presentation comes as Ethereum continues to compete with other blockchain platforms for market share in the smart contract and decentralized application space. Source: https://cryptobriefing.com/ethereum-roadmap-scaling-interoperability-security-japan/
Share
BitcoinEthereumNews2025/09/18 00:25
FCA komt in 2026 met aangepaste cryptoregels voor Britse markt

FCA komt in 2026 met aangepaste cryptoregels voor Britse markt

De Britse financiële waakhond, de FCA, komt in 2026 met nieuwe regels speciaal voor crypto bedrijven. Wat direct opvalt: de toezichthouder laat enkele klassieke financiële verplichtingen los om beter aan te sluiten op de snelle en grillige wereld van digitale activa. Tegelijkertijd wordt er extra nadruk gelegd op digitale beveiliging,... Het bericht FCA komt in 2026 met aangepaste cryptoregels voor Britse markt verscheen het eerst op Blockchain Stories.
Share
Coinstats2025/09/18 00:33
Monero Blows Past Its All-Time Price High as It Eyes a Top 10 Position

Monero Blows Past Its All-Time Price High as It Eyes a Top 10 Position

The privacy-focused crypto asset monero ( XMR) has been on a tear lately, with the digital currency clocking a new all-time high on Sunday, Jan. 11, 2026. Monero
Share
Coinstats2026/01/12 06:23